Transcenta to Hold 3 Exchange Sessions on Post-SITC Business Update Call & TST003 data release and pipeline development progress update
SUZHOU, China, Nov. 9, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical-stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development, and manufacturing of antibody-based therapeutics, announces that the management team will collaborate with major brokerage firms and asset management firms to organize three exchange sessions in November 2022 as follows: 1) Transcenta TST003 data release and...
Strong business performance in 9M/2022: Exyte increases order intake, sales, and profitability
Order intake up by more than 25% year-on-year, marking a new 9M-high with €6.5 billion Sales volume increased by almost 60% to €5.3 billion Strong increase in sales in all three business segments Adjusted EBIT increased by 73% to €308 million; adjusted EBITDA rose by 70% to €340 million Acquisition of...
NICOMATIC ANNOUNCES GLOBAL DISTRIBUTION PARTNERSHIP WITH PEI GENESIS
Harsh-Environment Connector Manufacturer Announces PEI Genesis as its latest Global Distributor HORSHAM, Pa., Nov. 9, 2022 /PRNewswire/ -- Nicomatic, a global manufacturer of creative harsh-environment interconnect solutions, announces a global distribution agreement with PEI-Genesis, headquartered in Philadelphia, Pennsylvania. The partnership will bring a key interconnect supplier to Nicomatic's growing distribution channel, enhancing...
Axiomtek launches the newest medical grade artificial intelligence computing system – mBOX100
TAIPEI, Nov. 9, 2022 /PRNewswire/ -- Axiomtek – a world-renowned leader relentlessly devoted to the research, development, and manufacturing of innovative and reliable industrial computer products of high efficiency – is pleased to announce the release of the mBOX100, a medical-grade edge AI computing system with dual 4K displays. This slim-type medical...
JW Therapeutics Announces its Cell Immunotherapy Drugs Have Successfully Benefited 300 Patients
SHANGHAI, Nov. 9, 2022 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced that as of November 8, 2022, its cell immunotherapy drugs (marketed products and candidate drugs included) have been successfully infused for treatment in 300 patients (clinical studies and commercialization included), bringing the hope...
Siemens Healthineers to demonstrate the remote capabilities of Corindus CorPath GRX Robotic System using Mentice VIST ® Simulator
GOTHENBURG, Sweden, Nov. 9, 2022 /PRNewswire/ -- Mentice, a world leader in simulation solutions for image-guided interventional therapies, announced today that Siemens Healthineers China is showcasing the remote capabilities of the Corindus CorPath GRX Robotic PCI system by using the Mentice VIST ® Virtual Patient simulator. This year's China International Import Expo (CIIE 2022) will be the first event to...
Smith+Nephew Academy Singapore opens, bringing medical education and digital innovation to healthcare professionals across Asia-Pacific
LONDON, Nov. 9, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the opening of Smith+Nephew (S+N) Academy Singapore, a major medical education and digital innovation centre covering the Asia-Pacific region today, in the presence of Mr Gan Kim Yong, Minister for Trade and Industry Singapore, Mr Alex Bamford, Deputy...
NEC Thailand conducts POC for elderly care in preparation for an aging society
BANGKOK, Nov. 9, 2022 /PRNewswire/ -- NEC Corporation (Thailand) Ltd. (NEC Thailand) has conducted a POC for elderly care in preparation for an aging society. The POC features a range of technological solutions designed to improve elderly care across Asia. The announcement follows a successful month-long trial in June at an elderly care...
TES Pharma Congratulates Intercept Pharmaceuticals on their Presentation of Phase 1 INT-787 Data at the AASLD Meeting and the Initiation of the Phase 2a FRESH Study in Patients with...
INT-787 is a selective next generation FXR agonist invented by TES Pharma and licensed to Intercept Pharmaceuticals INT-787 has shown strong anti-fibrotic and anti-inflammatory effects in animal models TES Pharma is dedicated to the identification of novel therapeutic targets and the discovery and development of new molecules to efficiently address the needs...
ScoliCare Opens its First Clinic in the US
New service will treat scoliosis and hyperkyphosis patients in Florida NAPLES, Fla. , Nov. 8, 2022 /PRNewswire/ -- ScoliCare, Australia's largest provider of non-surgical scoliosis and hyperkyphosis treatment and leading worldwide brace manufacturer (ScoliBrace®), today announced the opening of its first clinic in the United States. ScoliCare Naples Florida is located at 6291 Naples Blvd, Naples, Florida. To see case studies...
